GSK’s Dr Anne Phillips moves to Novo Nordisk
January 4, 2011Research and Development, Sales and Marketing Dr Anne Phillips, Novo Nordisk, apppointment, research and development, sales and marketing
Novo Nordisk has appointed Dr Anne Phillips as vice president for clinical, medical and regulatory affairs for North America. She …
Digital Pharma: First big pharma Android apps launched
January 4, 2011Medical Communications Android, Digital Pharma blog, Novartis, Sanofi-Aventis, apps, ipad, iphone
Big pharma’s smartphone marketing is starting to look beyond Apple’s attention-grabbing iPhone as companies produce the first apps for its …
NICE’s public health role reduced
January 4, 2011NHS, NHS reforms, NICE, public health, quality standards
NICE’s public health remit has been slimmed down as part of the government’s reforms with the removal of six areas …
Working Life: Astellas Pharma Europe’s chief operating officer
January 4, 2011Business Services, Sales and Marketing Astellas, Ken Jones, Working Life, recruitment
Ken Jones tells Pharmafocus about how his field is changing, starting with how he found his way into his current …
Achieve More in Phase I Studies
January 4, 2011Research and Development
Some individuals believe not much has changed in Phase 1 dose escalation studies. A recent review1 that looked at 105 …
Pharma manufacturing news in brief
January 4, 2011Manufacturing and Production Affinity Life Sciences, American Regent, Caraco Pharmaceutical Laboratories, Dr Reddy's Laboratories, Dr Reddy’s Laboratories, Huanggang Chuangxin Biochemicals, Kunming Quanxin Pharmaceutical Company, R-Pharm
An explosion at a Chinese pharma company causes five deaths, plus a round-up of product recalls, facility updates and other …
Italy: pioneering pay for performance in the age of austerity
January 4, 2011Sales and Marketing Drug pricing, Italy, cancer drug prices, price cuts
2010 saw Europe beset by economic turmoil, as governments have struggled with the effects of the downturn, including considerable public …
Novartis adds R&D unit to new vaccines plant
December 31, 2010Manufacturing and Production, Research and Development Novartis, pharma manufacturing, vaccines
Swiss drugmaker Novartis is planning to spend $36 million to set up an R&D laboratory on the site of its …
US healthcare ‘extreme makeover’ predicted for 2011
December 31, 2010Sales and Marketing US, US health reforms, US healthcare, health organisations, pricewaterhousecoopers, pwC
Health organisations in the US will undergo a strategic makeover in 2011 as they react to the pressures from new …
VTE trial boost for Pfizer and BMS’ apixaban
December 31, 2010Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, Pfizer, VTE, apixaban, enoxaparin, venous thromboembolism
Pfizer and Bristol-Myers Squibb’s oral anticoagulant apixaban has shown benefits over a standard injectable treatment for venous thromboembolism in a …
UCB plans €250m plant to meet Cimzia demand
December 29, 2010Manufacturing and Production Cimzia, Switzerland, UCB, pharma manufacturing
Belgian biotechnology company UCB has started construction of a new microbial manufacturing facility in Bulle, Switzerland to help meet demand …
SHL Expands Range of Automation Solutions for Auto Injector Assembly
December 29, 2010Manufacturing and Production assembly, auto injector, autoinjector, shl group
December 23, 2010 [Taoyuan, Taiwan]: With an increasing number of drug delivery devices, primarily auto injectors and pen injectors, under …
Pfizer expands Lipitor recall
December 24, 2010Manufacturing and Production Lipitor, Pfizer, manufacturing compliance, recalls
Pfizer has been forced to recall another 19,000 bottles of its cholesterol-lowering drug Lipitor in the US after consumers reported …
GSK’s patient access scheme for Votrient sways NICE
December 24, 2010Sales and Marketing GSK, GlaxoSmithKline, NICE, Votrient, pazopanib, rcc, renal cell carcinoma
NICE has recommended GlaxoSmithKline’s kidney cancer drug Votrient in final draft guidance after the pharma company offered to implement a …
Digital Pharma: Industry still cautious about social media
December 23, 2010Medical Communications Deloitte, Digital Pharma blog, doctors' social networks, social media, social networking
Life sciences companies remain cautious about using social networks, such as the healthcare professional community Sermo, largely because of a …
Novartis submits meningococcal vaccine Bexsero for European approval
December 23, 2010Sales and Marketing Bexsero, MenB, Novartis, Vaccine, bacterial meningitis, bloodstream infection sepsis, meningococcal disease, meningococcal vaccine
Novartis has submitted its meningococcal vaccine Bexsero to European regulators for marketing approval. If approved the drug will be the …
2010: Pharma’s year in review
December 23, 2010Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2010, Avandia, China, European healthcare spending, GSK, Obama, year in review
2010 saw a harsh new economic reality dominate decisions in the US and Europe, but pharma seized on opportunities in …
PCTs look to save millions with new cuts
December 23, 2010Sales and Marketing GP consortia, NHS, NHS cuts, NHS reforms, PCTs, generic prescribing
The NHS in England is cutting back on so-called ‘low priority’ procedures and looking to increase generic prescribing in order …
Gilead set to acquire Arresto for $225 million
December 23, 2010Research and Development AB0024, Arresto, Cancer, Gilead, advanced solid tumours, ambrisentan, fibrotic diseases, idiopathic pulmonary fibrosis
Gilead Sciences is set to acquire fellow California, US-based biotech Arresto for $225 million to bolster its early stage pipeline. …
Service Insight: New year, new resolution and priorities for 2011
December 23, 2010Medical Communications Jo Spadaccino, Pegasus PR, Service Insight, Talking Point
SERVICE INSIGHTNow the nights have drawn in and as Christmas music drives this writer to distraction, my attention has been …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
